ArriVent BioPharma Positioned for Success: Buy Rating on Strong Phase 3 Prospects and ...

Retrieved on: 2025-08-10 22:35:24

Tags for this article:

Click the tags to see associated articles and topics

ArriVent BioPharma Positioned for Success: Buy Rating on Strong Phase 3 Prospects and .... View article details on hiswai:

Excerpt

Analyst Soumit Roy from JonesTrading maintained a Buy rating on ArriVent BioPharma, Inc. and keeping the price target at $45.00.

Article found on: www.tipranks.com